Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129,337,627
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
534,782
-
Shares change
-
+534,782
-
Total reported value, excl. options
-
$1,176,000
-
Value change
-
+$1,176,000
-
Number of buys
-
9
-
Price
-
$2.19
Institutional Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q2 2018
As of 30 Jun 2018 ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) had 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 534,782 shares of stock of the company.
Largest 9 holders included SABBY MANAGEMENT, LLC, Anson Funds Management LP, VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, DEUTSCHE BANK AG\, BlackRock Inc., and Advisor Group, Inc..
This table shows 9 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.